Rockwell Medical (RMTI) Tops Q1 EPS by 2c, provides guidance
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $8.07 +2.02%
Revenue Growth %: +14.9%
Financial Fact:
Income Tax Expense: 0
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +14.9%
Financial Fact:
Income Tax Expense: 0
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q1 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $17.3 million versus the consensus estimate of $17.95 million.
GUIDANCE:
Rockwell Medical sees FY2026 revenue of $70-75 million, versus the consensus of $73.769 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Enablence closes C$25M private placement with Collingwood Investments
- Honeywell wins $53.9M Navy contract for navigation parts
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
